If you suddenly slide into sepsis, there’s a 50% chance you’ll survive. Because it is so hard to detect it.
Lab-on-Skin works to change it. And has the Mayo Clinic on their side.
Today you’ll hear about
continuous shock monitoring – to detect the earliest symptoms of sepsis
how to assess sepsis
nanotechnology, nanoelectronics, nanofluidics
and the unexplored wealth of our interstitial fluid
Esmeralda Megally is the CEO and co-founder of Xsensio. Having worked in the US on the launch of a new Investment Fund backed by the Bill & Melinda Gates Foundation, she found her entrepreneurship call in Switzerland.
Xsensio is a Swiss startup, a spinoff from the Nanolab at EPFL that develops Lab-on-Skin. It’s a medical-grade wearable that tracks biochemical information for continuous remote monitoring of patients at risk – sepsis for the start. But there's way more to come.
https://xsensio.com/
If you've enjoyed listening, you'll make us happy by clicking "Follow" on X-Health.show and leaving a review.
The information in this podcast is for informational purposes only and should not be considered medical advice. If you have any medical questions, please consult your healthcare practitioner. The opinions on the show are Alex's or her guests. The podcast does not make any responsibility or warranties about guests statements or credibility. While the podcast makes every effort to ensure that the information shared is accurate, please let us know if you have any comments, suggestions or corrections.